AstraZeneca Pharma India is trading higher by 4% to Rs 1,208, extending its Friday’s 9% rally, after its board approved the delisting proposal received from the Sweden based parent AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharmaceuticals AB holds 75% in AstraZeneca Pharma India, is planning to delist company’s equity shares from various bourses including the BSE and the National Stock Exchange (NSE).
Earlier this month, AstraZeneca Pharma had received by email a letter from AZP AB Sweden, promoter of the company, proposing to make a voluntary delisting offer to the public shareholders from BSE, NSE and Bangalore Stock Exchange.
The stock opened at Rs 1,224 and touched a high of Rs 1,249 on the NSE. A combined around 80,000 shares changed hands on the counter so far on the NSE and BSE.
AstraZeneca Pharmaceuticals AB holds 75% in AstraZeneca Pharma India, is planning to delist company’s equity shares from various bourses including the BSE and the National Stock Exchange (NSE).
Earlier this month, AstraZeneca Pharma had received by email a letter from AZP AB Sweden, promoter of the company, proposing to make a voluntary delisting offer to the public shareholders from BSE, NSE and Bangalore Stock Exchange.
The stock opened at Rs 1,224 and touched a high of Rs 1,249 on the NSE. A combined around 80,000 shares changed hands on the counter so far on the NSE and BSE.